Which are the factors contributing to obesity?
Obesity is a disease with many contributing factors, including genetics, behavior, environment, medical factors, central nervous system (CNS) pathways, and peripheral signals.1-3 The below factors have been suggested to contribute to the obesity epidemic (Table 1).
Category
Factor
Potential mechanisms
Effects on energy balance
Genetic2,4,5
Variations in BMI
Changes in genes responsible for weight and / or metabolism (epigenetics, deletions, single nucleotide polymorphisms)
Variable
↑ Energy intake and variable energy expenditure
Behavioral2,6-8
Diet, inactivity, emotional factors
Multiple behavioral mechanisms
↑ Energy intake and variable energy expenditure
Lack of sleep
Multiple hormonal mechanisms: mostly leptin - and ghrelin - induced changes in appetite
↑ Energy intake and variable energy expenditure
Smoking cessation
Behavioral effect
↑ Energy intake and
↓ Energy expenditure
Environmental2,4,6,7,9
Access to/affordability of food, socioeconomic status, stress, physical environment, endocrine disruptors, gut microbiome
Multiple behavioral mechanisms
↑ Energy intake and variable energy expenditure
Medical1,2,10-13
Pharmaceuticals such as corticosteroids and certain psychiatric drugs
Variable
↑ Energy intake and
↓ Energy expenditure
Diseases and conditions such as Polycystic Ovarian Syndrome (PCOS), Cushing’s syndrome, hypothyroidism, pregnancy-related weight gain, menopause, low testosterone
Variable
↑ Energy intake and variable energy expenditure
CNS pathways3,13
Homeostatic and reward system pathways
Energy regulation in hypothalamus, dopamine reward system
↑ Energy intake and variable energy expenditure
Peripheral signals2,3
Hormones and gastrointestinal peptides [insulin, leptin, ghrelin, glucagon-like peptide 1 (GLP-1), cholecystokinin (CCK), amylin, peptide YY (PYY)]
Mostly leptin - and ghrelin - induced changes in appetite
Variable
BMI=Body mass index, CCK=Cholecystokinin, CNS=Central nervous system,
GLP-1=Glucagon-like peptide 1, PCOS=Polycystic ovarian syndrome, PYY=Peptide YY
References
1. Jensen MD. Goldman's Cecil Medicine. 24th ed. Philadelphia, PA: Saunders Elsevier; 2012:1409-1417.
2. Cizza G et al J Endocrinol Invest. 2012;35:1-14.
3. Volkow ND et al. Obes Rev. 2013;14(1):2-18.
4. Nguyen DM et al. Gastroenterol Clin North Am. 2010;39:1-7.
5. Hjelmborg J et al. Obesity 2008;16:847-852.
6. Ahima RS. J Clin Invest. 2011;121:2076-2079.
7. Puhl RM et al. Am J Public Health. 2010;100:1019-1028.
8. Mackay DF et al. BMC Public Health. 2013;13:348.
9. Kushner RF et al. Psychiatr Clin North Am. 2011;34:797-812.
10. Robertson A et al. http://ec.europa.eu/health/ph_determinants/life_style/nutrition/documents/ev20081028_rep_en.pdf. Accessed 15 August 2016.
11. Gunderson EP. Obstet Gynecol Clin North Am. 2009;36:317- ix.
12. Wang C et al. Diabetes Care. 2011;34:1669-1675.
13. Schwartz MW et al. Nature. 2000;404:661-671.